A Double-blind, Randomised, Placebo-controlled Study to Evaluate Three Doses of ToleroMune Grass in Grass Allergic Subjects Following Challenge With Grass Allergen in an Environmental Exposure Unit.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2015
At a glance
- Drugs Grass SPIRE (Primary)
- Indications Allergic rhinoconjunctivitis; Grass pollen hypersensitivity
- Focus Therapeutic Use
- Sponsors Circassia
- 01 Oct 2013 Results have been reported in a Circassia media release.
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Oct 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History